Immunogenic polypeptides for inducing anti-self IgE responses

Details Immunogenic polypeptides for inducing anti-self IgE responses Immunogenic polypeptides for inducing anti-self IgE responses

2005-07-05

2005-07-05

Chan, Christina (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Amino acid sequence disclosed in whole or in part; or...

C424S192100, C530S387300

Reexamination Certificate

active

06913749

ABSTRACT:
The invention relates to methods and materials involved in the treatment and prevention of various diseases such as infections and IgE-related diseases. Specifically, the invention relates to methods and materials that can be used to vaccinate a mammal against specific self or non-self antigens. For example, the methods and materials described herein can be used to reduce the effects of IgE antibodies within a mammal by reducing the amount of total and receptor bound IgE antibodies in the mammal. In addition, the invention provides vaccine conjugates, immunogenic polypeptides, nucleic acid molecules that encode immunogenic polypeptides, host cells containing the nucleic acid molecules that encode immunogenic polypeptides, and methods for making vaccine conjugates and immunogenic polypeptides as well as nucleic acid molecules that encode immunogenic polypeptides. Further, the invention provides an IgE vaccine that induces an anti-self IgE response in a mammal.

REFERENCES:
patent: 4483793 (1984-11-01), Vyas
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4703004 (1987-10-01), Hopp et al.
patent: 4767842 (1988-08-01), Stevens
patent: 4782137 (1988-11-01), Hopp et al.
patent: 4873191 (1989-10-01), Wagner et al.
patent: 5175384 (1992-12-01), Krimpenfort et al.
patent: 5175385 (1992-12-01), Wagner et al.
patent: 5196197 (1993-03-01), Talwar et al.
patent: 5254671 (1993-10-01), Chang
patent: 5501855 (1996-03-01), Talwar et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5589466 (1996-12-01), Felgner et al.
patent: 5653980 (1997-08-01), Hellman et al.
patent: 5698201 (1997-12-01), Stevens
patent: 5733553 (1998-03-01), Talwar et al.
patent: 5762931 (1998-06-01), Talwar et al.
patent: 5827668 (1998-10-01), Stanworth et al.
patent: 5837686 (1998-11-01), Kirby et al.
patent: 5945104 (1999-08-01), Stanworth et al.
patent: 5955076 (1999-09-01), Stanworth et al.
patent: 6034066 (2000-03-01), Johnson et al.
patent: 2002/0141989 (2002-10-01), Kricek et al.
patent: 2117193 (1993-04-01), None
patent: 2320960 (1999-02-01), None
patent: 0 327 378 (1989-08-01), None
patent: 0 396 505 (1990-11-01), None
patent: 0 403 312 (1990-12-01), None
patent: 0 752 886 (1998-01-01), None
patent: 0 841 946 (2002-10-01), None
patent: 1 009 382 (2003-06-01), None
patent: 0 821 003 (2003-08-01), None
patent: WO 89/04834 (1989-06-01), None
patent: WO 89/06138 (1989-07-01), None
patent: WO 91/01146 (1991-02-01), None
patent: WO 91/11456 (1991-08-01), None
patent: WO 94/05698 (1994-03-01), None
patent: WO 94/08601 (1994-04-01), None
patent: WO 95/05849 (1995-03-01), None
patent: WO9526356 (1995-10-01), None
patent: WO 95/26365 (1995-10-01), None
patent: WO 96/12740 (1996-05-01), None
patent: WO 97/22699 (1997-06-01), None
patent: WO 98/05684 (1998-02-01), None
patent: WO 98/46642 (1998-10-01), None
patent: WO 99/62550 (1999-12-01), None
patent: WO 99/67293 (1999-12-01), None
patent: WO 00/20027 (2000-04-01), None
patent: WO 00/32227 (2000-06-01), None
patent: WO 00/65058 (2000-11-01), None
patent: WO 02/09751 (2002-02-01), None
patent: WO 02/20038 (2002-03-01), None
patent: WO02/102320 (2002-12-01), None
Attwood et al, The Babel of Bioinformatics, 2000 Science vol. 290 No. 5491: 471-473.
Nissim et al, EMBO J 10(1): 101-107, 1991.
Ngo et al, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Nissim et al. Comp. to Meth. Enzmol., p. 124-131, 1995.
Nechansky et al, Int Arch Allergy Immunol. Dec., 1999;120(4):295-302.
Abaza et al, J of Protein Chemistry 11(5): 433-444, 1992.
Kuby et al., 1994, Immunology, second etition, pp. 85-96.
Stryer et al, in Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Aveskogh et al, Eur J Immunol 28(9): 2738-50.
Jaffery et al, Immunology 78(4): 635-42, Apr. 1993.
Demoly et al, Am J Respir Crit Care Med 156(5): 1707, Nov. 1997.
Keegan et al, Mol Immunol 28(10): 1149-54, Oct. 1991.
Presta et al, J Biol Chem 269(42): 26368-73, Oct. 1994.
Basu et al, J Biol Chem 269 268(18): 13118-13127, 1993.
Hellman et al, in New Horizons in Allergy Immunotherapy, Plenum Press, New York, 1996, pp. 337-342.
Paul et al (in Fundamental Immunology second edition, p. 826, Raven Press, New York, 1989.
Fahy et al, Am J Respir Crit Care Med 155(6): 1824-34, Jun. 1997.
Demoly and Bousquet, “Anti-IgE Therapy for Asthma,”Am. J. Respir. Crit. Care. Med., 1997, 155:1825-1827 (Erratum, only).
Fahy et al., “The Effect of an Anti-IgE Monoclonal Antibody on the Early- and Late-Phase Responses to Allergen Inhalation in Asthmatic Subjects,”Am. J. Respir. Crit. Care Med., 1997. 155:1828-1834.
Jaffery et al., “Induction of an auto-anti-IgE response in rats. IV. Effects on mast cell degranulation.”Immunology, 1993, 78:635-642.
Nechansky et al., “Interaction of Human IgE with Fc Epsilon RI Alpha Exposes Hidden Epitopes on IgE,”Int. Arch. Allergy Immunol., 1999, 120:295-302.
Paul (ed.),Fundamental Immunology, 2ndedition, 1989, Raven Press, New York, pp. 826-827.
Basu et al., “Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor,”J. Biol. Chem.,1993, 268(18):13118-13127.
Nissum et al., “Fine Specificity of the IgE Interaction with the Low and High Affinity Fc Receptor,”J. Immunol.,1993, 150(4):1365-1374.
Liou et al.,J. Immunol.,143:3967-3975 (1989).
Baniyash, et al.,Molecular Immunology,1988, 25(8):705-711.
Basciano, et al.,J. of Biol. Chem.,1986, 261(25):11823-11831.
Burt, et al.,Eur. J. Immunol.,1987, 17:437-440.
Burt, et al.,Molecular Immunology,1986, 23(2):181-191.
Coleman, et al.,Eur. J. Immunol.,1985, 15:966-969.
Geha,Annals of Allergy,1991, Letter to the Editor, 66(5):359-360.
Geha, et al.,Nature,1985, 315:577-581.
Gould,Clinical and Experimental Allergy,1991, 21, Supp. 1.
Haba, et al.,Journal of Immunological Methods,1987, 105:193-199.
Haba, et al.,Proc. Natl. Acad. Sci.,1987, 84:5009-5013.
Haba, et al.,Proc. Natl. Acad. Sci.,1990, 87:3363-3367.
Hamburger,American Scientist,1976, 64:157-164.
Hamburger,Annals of Allergy,Letter to the Editor, Jan. 1992, 68(1).
Hamburger,Science,1975, 189:389-390.
Hamburger,Immunology,1979, 38(4):781-787.
Hamburger,IgE and Allergy,95-112.
Holgate,The Practioner,1989, 233:599-602.
Ishizaka,Advances in Immunology,1989, 47:1-43.
Ishizaka, et al.,Proc. Natl. Acad. Sci.,1986, 83:8323-8327.
Johansson,Anti-IgE Antibodies in Human Serum, J. Allergy Clin. Immunol.,1986, 77(4):555-557.
Koike, et al.,Monogr Allergy,1989, 26:165-175.
Liou, et al.,Journal of Immunology,1989, 143:3967-3975.
Marshall, et al.,Eur. J. Immunol.,1985, 15:272-277.
Marshall, et al.,Eur. J. Immunol.,1987, 17:445-451.
Marshall, et al.,Immunology,1989, 66(3):428-433.
Michel, et al.,J. Allergy Clin. Immunol.,1986, 1022-1027.
Nagpal, et al.,Journal of Immunology,1989, 142(10):3411-3415.
Neuberger, et al.,Nature,1985, 314(21):268-270.
Noro, et al.,Journal of Immunology,1986, 137(4):1258-1263.
Padlan, et al.,Molecular Immunology,1986, 23(10):1063-1075.
Robertson, et al.,Molecular Immunology,1988, 25(2):103-113.
Sarfati, et al.,Eur. J. Immunol.,1986, 16:325-331.
Slater, et al.,Journal of Immunology,1988, 140:807-811.
Stanworth,Use of Synthetic Peptides in the Delineation of the Role of Non-Antigen Receptors in Mast Cell Signalling Processes,213-222.
Stanworth, et al.,Molecular Immunology,1984, 21(12):1183-1190.
Stanworth, et al.,The Use of Synthetic Peptides in the Delineation of Immunoglobulin Antigenic Epitopes and Fc Effector Functions,226-244.
Stanworth, et al.,Biochem. J.,1979, 180:665-668.
Suemura, et al.,Journal of Immunology,1986, 137(4):1214-1220.
Weyer, et al.,Agents and Actions,1987, 20, ¾:210-212.
Weyer, et al.,Agents and Actions,1987, 20 ¾:206-209.
Vichyanond,Asian Pacific Journal of Allergy and Immunology,1990, 8:1-4.
Chemical Abstracts, vol. 129 (Columbus, Ohio), Griot-Wenk, M. E. et al., “Characterization of two dog IgE-specific antibodies elicited by different recombinant fragments of the epsilon chain in hens,” p. 1, Abstract No. 107756, Vet. Immunol. Immunopathol. 1998, 64(1): A

Affiliated with

Also associated with

Rating

Immunogenic polypeptides for inducing anti-self IgE responses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunogenic polypeptides for inducing anti-self IgE responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic polypeptides for inducing anti-self IgE responses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3386778